Structures by: Chantrapromma K.
Total: 26
6-Hydroxymexicanolide
C27H32O8
Acta Crystallographica Section E (2004) 60, 2 o312-o314
a=10.6293(6)Å b=10.7405(6)Å c=21.4937(13)Å
α=90.00° β=90.00° γ=90.00°
Pinnatin
C18H12O4
Acta Crystallographica Section E (2006) 62, 5 o1984-o1986
a=8.61740(10)Å b=15.5622(3)Å c=9.86340(10)Å
α=90.00° β=96.9450(10)° γ=90.00°
(C42H44Cl2N6O6Zn2),1.75C2H6O,0.25H2O
(C42H44Cl2N6O6Zn2),1.75C2H6O,0.25H2O
Acta Crystallographica Section E (2002) 58, 7 m344-m346
a=26.0725(4)Å b=9.58360(10)Å c=19.74830(10)Å
α=90.00° β=103.6580(10)° γ=90.00°
14β-hydroxy-3β-o-(L-thevetosyl)-5β-card-20(22)-enolide dichloroform solvate
C30H46O8,2CHCl3
Acta Crystallographica Section E (2003) 59, 11 o1694-o1696
a=7.6426(4)Å b=9.1932(5)Å c=54.362(3)Å
α=90.00° β=90.00° γ=90.00°
Methyl 4-(3,5-dimethoxy-2-methylphenoxy)-2,6-dihydroxy-3-iodo-5-methylbenzoate
C18H19IO7
Acta Crystallographica Section E (2001) 57, 11 o1047-o1049
a=8.8878(3)Å b=10.6008(2)Å c=11.2792(3)Å
α=62.2530(10)° β=87.8720(10)° γ=82.9530(10)°
A cocrystal of clusiacitran A, clusiacitran B, (10-fluoro-9-hydroxy-1,5,5-trimethyl-6,15-dioxatetracyclo[9.3.10^4,13^.0^7,12^] pentadeca-7,9-11-trien-8,yl)phenyl-methanone and (10-fluoro-9-hydroxy-1,5,5-trimethyl-6,15-dioxatetracyclo[9.3.10^4,13^.0^7,12^] pentadeca-7,9-11-trien-10,yl)phenyl-methanone (0.45:0.45:0.05:0.05)
0.45C23H24O4,0.45C23H24O4,0.05C23H23FO4,0.05C23H23FO4
Acta Crystallographica Section E (2006) 62, 8 o3228-o3230
a=9.6691(2)Å b=10.5583(2)Å c=18.9279(3)Å
α=90.00° β=103.1600(10)° γ=90.00°
7a-O-methyldeguelol
C24H25O6
Acta Crystallographica Section E (2005) 61, 8 o2340-o2342
a=9.7861(14)Å b=10.4999(15)Å c=10.7337(15)Å
α=72.329(3)° β=88.734(3)° γ=84.930(3)°
1-[4-(3,5-Dimethoxy-2-methylphenoxy)-2,6-dihydroxy-3-methylphenyl]ethanone
C18H20O6
Acta Crystallographica Section E (2001) 57, 1 o18-o19
a=7.4228(2)Å b=10.14600(10)Å c=11.3559(3)Å
α=102.4740(10)° β=90.989(2)° γ=98.544(2)°
2,3-Dihydro-8-hydroxy-5,7-dimethoxy-2-phenyl-4H-1-benzopyran-4-one
C17H16O5
Acta Crystallographica Section C (1998) 54, 2 IUC9800001
a=36.858(5)Å b=6.5975(10)Å c=12.145(2)Å
α=90.00° β=101.255(10)° γ=90.00°
2,3-Dihydro-8-hydroxy-5,7-dimethoxy-3,3,6-tribromo-2-phenyl-4H-1-benzopyran- 4-one
C17H13Br3O5
Acta Crystallographica Section C (1998) 54, 2 IUC9800001
a=8.945(3)Å b=8.664(2)Å c=47.029(9)Å
α=90.00° β=90.00° γ=90.00°
2,3-Dihydro-6,7-dimethyl-2-phenyl-4H-1-benzopyran-4-one
C17H16O2
Acta Crystallographica Section C (1998) 54, 3 IUC9800007
a=5.057(2)Å b=11.046(2)Å c=12.531(2)Å
α=88.525(14)° β=87.03(2)° γ=79.29(2)°
Onysilin
C17H16O5
Acta Crystallographica Section C (1997) 53, 6 734-736
a=9.722(3)Å b=7.475(2)Å c=20.255(5)Å
α=90.00° β=99.750(10)° γ=90.00°
2,6-dihydroxy-4-(6'-hydroxy-2',4'-dimethoxy-3'-methylbenzoyloxy)-3- methylbenzoate
C19H20O9
Acta Crystallographica Section C (1998) 54, 10 1494-1496
a=8.4255(2)Å b=8.5771(2)Å c=14.5531(2)Å
α=89.6920(10)° β=85.374(2)° γ=61.2950(10)°
7-Glycoloyl-2-hydroxy-1,4b,7,10a-tetramethyl-4a,4b,5,6,7,8,8a,9,10,10a- decahydro-3(4H)-phenanthrenone
C20H30O4
Acta Crystallographica Section E (2007) 63, 2 o459-o461
a=7.8316(4)Å b=21.0250(9)Å c=32.0885(13)Å
α=90.00° β=90.00° γ=90.00°
Secodukunolide F
C27H32O9
Acta Crystallographica Section E (2006) 62, 9 o3725-o3727
a=7.9634(5)Å b=14.6700(9)Å c=20.5420(13)Å
α=90.00° β=90.00° γ=90.00°
Tagalsin F
C20H30O2
Acta Crystallographica Section E (2006) 62, 12 o5539-o5541
a=6.6826(2)Å b=10.8100(3)Å c=23.8901(6)Å
α=90.00° β=90.00° γ=90.00°
8-Methyleugenitin
C13H14O4
Acta Crystallographica Section E (2007) 63, 4 o2017-o2019
a=8.0816(2)Å b=8.6719(2)Å c=15.8187(4)Å
α=90.00° β=91.3010(10)° γ=90.00°
(<i>E</i>)-2-Hydroxy-4'-methoxyazastilbene
C14H13NO2
Acta Crystallographica Section E Crystallographic Communications (2015) 71, 6 571
a=8.0357(3)Å b=5.5554(2)Å c=12.8733(5)Å
α=90.00° β=101.3120(10)° γ=90.00°
3β-o-(L-thevetoyl)-14β-hydroxy-5β-card-20(22)-enolide methanol solvate monohydrate
2C30H46O8,CH4O,H2O
Acta Crystallographica Section C (2003) 59, 2 o68-o70
a=10.4353(5)Å b=10.4491(5)Å c=14.8760(7)Å
α=92.4120(10)° β=101.4710(10)° γ=109.5990(10)°
3β-o-(L-2-o-acetyl thevetoyl)-14β-hydroxy-5β-card-20(22)-enolide
C32H48O9
Acta Crystallographica Section C (2003) 59, 2 o68-o70
a=7.3351(3)Å b=21.4770(9)Å c=9.9056(4)Å
α=90.00° β=97.0070(10)° γ=90.00°
Cerbinal
C11H8O4
Acta Crystallographica Section C (2001) 57, 11 1352-1353
a=6.8622(2)Å b=10.82440(10)Å c=12.3446(3)Å
α=90.00° β=90.00° γ=90.00°
2-(4-Acetyl-3,5-dihydroxy-2-methylphenoxy)-4,6-dimethoxy-3-methylbenzoic acid
C19H20O8
Acta Crystallographica Section C (2000) 56, 12 e598-e599
a=6.0228(3)Å b=24.7920(10)Å c=12.1890(10)Å
α=90.00° β=100.9280(10)° γ=90.00°
Brasilixanthone
C23H20O6
Acta Crystallographica Section E (2010) 66, 8 o2066-o2067
a=7.5842(3)Å b=12.2937(4)Å c=19.6023(6)Å
α=90.00° β=96.827(2)° γ=90.00°
Pruniflorone M monohydrate
C18H16O6,H2O
Acta Crystallographica Section E (2011) 67, 8 o1916-o1917
a=9.8887(3)Å b=15.6028(4)Å c=20.4857(5)Å
α=90.00° β=90.00° γ=90.00°
2-(2,4,5-Trimethoxyphenyl)-2,3-dihydroquinolin-4(1<i>H</i>)-one
C18H19NO4
Acta Crystallographica Section E (2012) 68, 3 o664-o665
a=10.7354(11)Å b=17.1525(16)Å c=8.6471(8)Å
α=90.00° β=102.981(2)° γ=90.00°
<i>ent</i>-15<i>S</i>-prima-8(14)-ene-15,16-diol Ceriotagalsin L
C20H34O2
Acta Crystallographica Section E (2012) 68, 2 o520-o521
a=11.5129(2)Å b=7.09340(10)Å c=22.3946(4)Å
α=90.00° β=96.7500(10)° γ=90.00°